EUVIMEDEUVIMED entdecken
Crossref

An APE1-CRISPR/Cas12a cascaded amplification platform for breast cancer-related microRNA analysis

Ruixuan Zhou, Ying Wei, Xingxing Liu, Xiaoyun Lei, Yongan Ren, Keming Ying

New Journal of Chemistry · 2026 · 50 (30) · 12648-12654

DOI: 10.1039/d6nj01779g ↗

Kurz gefasst

Fachartikel in der Zeitschrift New Journal of Chemistry, 2026. Verfasst von Ruixuan Zhou und 5 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An APE1-CRISPR/Cas12a cascaded platform achieves a detection limit of 4.5 fM for miRNA, and demonstrates robust diagnostic accuracy in breast cancer patient plasma with an AUC of 0.92.

Zitieren

APA

Zhou, R., Wei, Y., Liu, X., Lei, X., Ren, Y., & Ying, K. (2026). An APE1-CRISPR/Cas12a cascaded amplification platform for breast cancer-related microRNA analysis. New Journal of Chemistry, 50(30), 12648-12654. https://doi.org/10.1039/d6nj01779g

Vancouver

Zhou R, Wei Y, Liu X, Lei X, Ren Y, Ying K. An APE1-CRISPR/Cas12a cascaded amplification platform for breast cancer-related microRNA analysis. New Journal of Chemistry. 2026;50(30):12648-12654. doi:10.1039/d6nj01779g

BibTeX
@article{Zhou2026,
  author = {Zhou, Ruixuan and Wei, Ying and Liu, Xingxing and Lei, Xiaoyun and Ren, Yongan and Ying, Keming},
  title = {An APE1-CRISPR/Cas12a cascaded amplification platform for breast cancer-related microRNA analysis},
  journal = {New Journal of Chemistry},
  year = {2026},
  volume = {50},
  number = {30},
  pages = {12648--12654},
  doi = {10.1039/d6nj01779g}
}
Kostenlos starten →